THE EFFECT OF TREATMENT OF HYPERAND HYPOTHYROIDISM ON URINARY EXCRETION OF CYCLIC ADENOSINE 3′,5′-MONOPHOSPHATE

1977 ◽  
Vol 84 (3) ◽  
pp. 542-547 ◽  
Author(s):  
D. J. Carter ◽  
D. A. Heath

ABSTRACT The urinary excretion of cyclic adenosine 3′,5′-monophosphate (cyclic AMP) was examined in patients with hyperthyroidism and primary hypothyroidism, before treatment and at least six months later on return to euthyroid status. Urinary cyclic AMP excretion was significantly greater in the hyperthyroid group than in the hypothyroid group both in the basal state (P < 0.01) and the ambulant state (P < 0.001). In ambulant hyperthyroid patients absolute urinary cyclic AMP excretion (μmol/24 h) was significantly greater (P < 0.05) prior to treatment than on return to euthyroid status. In the hypothyroid group no significant change occurred after treatment with 1-thyroxine (P > 0.05). The mechanism of changes in urinary cyclic AMP excretion in thyroid disease are discussed.

1974 ◽  
Vol 47 (5) ◽  
pp. 19P-20P
Author(s):  
D. J. Carter ◽  
D. A. Heath ◽  
R. Hoffenberg

1984 ◽  
Vol 106 (4) ◽  
pp. 477-481 ◽  
Author(s):  
M. A. B. Naafs ◽  
P. C. van der Velden ◽  
H. R. A. Fischer ◽  
G. Koorevaar ◽  
S. van Duin ◽  
...  

Abstract. Plasma cyclic AMP (PcAMP) concentration and the excretion of cyclic AMP dl GF were estimated in 11 thyrotoxic patients before and after medical treatment. PcAMP concentrations were significantly higher during hyperthyroidism (2.30 ± 0.69 vs 1.88 ± 0.71 nmoldl; P < 0.05), and total urinary cyclic AMP (TcAMP) excretion showed no significant changes (3.24 ± 0.64 vs 3.44 ± 1.77 nmol/dl GF). Nephrogenous (NcAMP) excretion rose significantly (1.00 ±0.82 vs 1.68 ±1.31 mmol/dl GF; P < 0.025). The increase in NcAMP excretion correlated significantly with the decrease in serum T3 levels (r = -0.46; P < 0.05). Serum iPTH levels showed no significant change. Both the serum Ca, corrected for serum total protein and TmPO4 GFR declined after treatment (respectively 2.44 ± 0.13 vs 2.33 ± 0.08 mmol l; P <0.05 and 1.18 ± 0.29 vs 1.05 ±0.22 mmol/l; P < 0.05). It is concluded that the rise in NcAMP excretion corroborates the concept of increasing parathyroid activity following the treatment of hyperthyroidism.


1974 ◽  
Vol 125 (588) ◽  
pp. 457-458 ◽  
Author(s):  
R. P. Hullin ◽  
J. G. Salway ◽  
M. N. E. Allsopp ◽  
Janet D. M. Albano ◽  
G. Dawn Barnes ◽  
...  

Various reports have suggested that the urinary excretion of adenosine cyclic 3'5’ monophosphate (cyclic AMP) is increased in mania and decreased in depression. However, our own serial studies from short-cycle bipolar manic-depressive patients showed no correlation between mood and cyclic AMP excretion (2). Jenner et al. (4) confirmed our findings, except in the case of a patient with a regular 48-hour mood cycle who did show a correlation between his mood changes and changes in cyclic AMP excretion. Paul et al. (5) also reported a general lack of correlation between these variables, but found a transient increase of urinary cyclic AMP during the rapid switch from depression to mania. We have investigated the situation in a bipolar patient who shows such a rapid switch in mood but have been unable to demonstrate any increase in cyclic AMP excretion during the switch period.


1974 ◽  
Vol 125 (586) ◽  
pp. 275-279 ◽  
Author(s):  
Graham J. Naylor ◽  
David A. Stansfield ◽  
Susan F. Whyte ◽  
Frederick Hutchinson

Changes in the excretion of adenosine 3’:5′-cyclic monophosphate (cyclic AMP) have been reported in depressive illness. Abdulla and Hamadah (1970) reported that urinary cyclic AMP excretion was lower than normal during depression and increased with recovery. However, these results were based on single 24-hour urine collections during depression and on recovery, with no creatinine estimations to suggest that the collections were complete. There was no control of diet, drugs or activity. The controls do not appear to have been matched for age. Paul, Ditzion, Pauk and Janowsky (1970) reported that the cyclic AMP excretion in neurotic depression was higher and in psychotic depression was lower than in a control group, but neither difference was statistically significant. However, on enlarging the study by including more psychotic depressives they reported that the cyclic AMP excretion of this group was significantly less than that of the controls (Paul, Cramer and Goodwin, 1971). These workers had controlled the patients' drug and dietary (but not fluid) intake. There appeared to be only minimal control of activity. The results were based on approximately two samples of urine per subject, which were very carefully checked for completeness of collection. Unfortunately the age of the controls (19–22 years) was very different from that of the patients (25–64 years). On two small groups of patients treated with either Laevodopa or lithium carbonate, they reported that changes in affective state were accompanied by changes in the urinary excretion of cyclic AMP. However, in serial studies on manic-depressive patients Paul, Cramer and Bunney (1971) failed to show a correlation between mood rating and cyclic AMP excretion in five out of seven patients; but they reported that the cyclic AMP excretion was increased on the day of rapid switch from depression to mania. The above groups of workers had used an enzymatic-isotope displacement technique to estimate the cyclic AMP. Brown, Salway, Albano, Hullin and Ekins (1972), using a saturation method to assay cyclic AMP, found no correlation between mood and cyclic AMP excretion in two short-cycle manic-depressive patients. Jenner, Sampson, Thompson, Somerville, Beard and Smith (1972) wrote: ‘We have measured daily excretion by a number of depressed and manic depressive patients over periods covering several mood changes without being able to establish any consistent correlation between cyclic AMP excretion and mood, … However, in one unusual case we have found a very marked correlation‘. We (Naylor, Dick, Dick, Moody and Stansfield, 1974) were unable to demonstrate any relationship between urinary cyclic AMP excretion and mood in a patient with recurrent psychotic episodes, in which depressive features predominated.


1977 ◽  
Vol 84 (2) ◽  
pp. 343-348 ◽  
Author(s):  
Robert Perlstein ◽  
Lowell Kopp ◽  
Joseph R. Tucci

ABSTRACT The present studies demonstrate that the administration of pharmacologic amounts of ACTH is associated with small but significant increases in urinary cyclic AMP excretion and in urinary cyclic AMP/creatinine ratios which are most likely related to a release of cyclic AMP from adrenocortical tissue. Acute suppression of the pituitary-adrenal axis with dexamethasone and stimulation with metyrapone, however, is not associated with changes in urinary cyclic AMP excretion. These results suggest that physiological levels of ACTH and cortisol contribute little, if any, to the urinary excretion of cyclic AMP in man.


1965 ◽  
Vol 32 (1) ◽  
pp. 107-115 ◽  
Author(s):  
J. B. BROWN ◽  
J. A. STRONG

SUMMARY The urinary excretion of endogenous and exogenous oestrogens was studied in patients with disordered thyroid function, and in obese and non-obese patients without evident thyroid disease. Hypothyroid patients and obese patients converted a larger percentage of administered oestradiol-17β to urinary oestriol and a lower percentage to urinary oestrone than hyperthyroid patients and non-obese patients. The recovery of administered oestradiol as oestriol, oestrone and oestradiol in urine was the same in the hypothyroid, obese and non-obese patients but considerably lower in the hyperthyroid patients. Similar differences were found in the urinary excretion of endogenous oestrogens. The excretion of endogenous oestrogens varies with the weight of the patient; it was greater in the obese than in the non-obese. The findings indicate that the pathways of oestrogen metabolism are influenced by a number of the factors, including thyroid function, associated with the weight of the patient.


1991 ◽  
Vol 23 (3) ◽  
pp. 201-206
Author(s):  
John L. Stock ◽  
James A. Coderre ◽  
James A. Simon

Sign in / Sign up

Export Citation Format

Share Document